These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27799019)

  • 1. An RCT Evaluating the Effects of Skills Training and Medication Type on Work Outcomes Among Patients With Schizophrenia.
    Glynn SM; Marder SR; Noordsy DL; O'Keefe C; Becker DR; Drake RE; Sugar CA
    Psychiatr Serv; 2017 Mar; 68(3):271-277. PubMed ID: 27799019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone versus olanzapine among patients with schizophrenia participating in supported employment: Eighteen-month outcomes.
    Noordsy DL; Glynn SM; Sugar CA; O'Keefe CD; Marder SR
    J Psychiatr Res; 2017 Dec; 95():299-307. PubMed ID: 28942217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A group cognitive behavioral intervention for people registered in supported employment programs: CBT-SE].
    Lecomte T; Corbière M; Lysaker PH
    Encephale; 2014 Jun; 40 Suppl 2():S81-90. PubMed ID: 24948482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Work Outcome in Supported Employment for Serious Mental Illness: Results From 2 Independent Studies of Errorless Learning.
    Kern RS; Zarate R; Glynn SM; Turner LR; Smith KM; Mitchell SS; Sugar CA; Bell MD; Liberman RP; Kopelowicz A; Green MF
    Schizophr Bull; 2018 Jan; 44(1):38-45. PubMed ID: 28981901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training.
    Nuechterlein KH; Subotnik KL; Ventura J; Turner LR; Gitlin MJ; Gretchen-Doorly D; Becker DR; Drake RE; Wallace CJ; Liberman RP
    Psychol Med; 2020 Jan; 50(1):20-28. PubMed ID: 30606273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
    Ren XS; Lee AF; Huang YH; Hamed A; Herz L; Miller DR; Kazis LE
    J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
    Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Individual Placement and Support Supplemented With Cognitive Remediation and Work-Focused Social Skills Training for People With Severe Mental Illness: A Randomized Clinical Trial.
    Christensen TN; Wallstrøm IG; Stenager E; Bojesen AB; Gluud C; Nordentoft M; Eplov LF
    JAMA Psychiatry; 2019 Dec; 76(12):1232-1240. PubMed ID: 31483451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Supported Employment for People With Schizophrenia in Mainland China: A Randomized Controlled Trial.
    Zhang GF; Tsui CM; Lu AJB; Yu LB; Tsang HWH; Li D
    Am J Occup Ther; 2017; 71(6):7106165020p1-7106165020p8. PubMed ID: 29135426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three year follow-up study of an integrated supported employment for individuals with severe mental illness.
    Tsang HW; Fung KM; Leung AY; Li SM; Cheung WM
    Aust N Z J Psychiatry; 2010 Jan; 44(1):49-58. PubMed ID: 20073567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effects of olanzapine and risperidone versus placebo on ghrelin plasma levels.
    Roerig JL; Steffen KJ; Mitchell JE; Crosby RD; Gosnell BA
    J Clin Psychopharmacol; 2008 Feb; 28(1):21-6. PubMed ID: 18204336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model.
    Vera-Llonch M; Delea TE; Richardson E; Rupnow M; Grogg A; Oster G
    Value Health; 2004; 7(5):569-84. PubMed ID: 15367252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.
    Konarzewska B; Wołczyński S; Szulc A; Galińska B; Popławska R; Waszkiewicz N
    Psychoneuroendocrinology; 2009 Jan; 34(1):129-39. PubMed ID: 18838228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardizing measures in four domains of employment outcomes for individual placement and support.
    Bond GR; Campbell K; Drake RE
    Psychiatr Serv; 2012 Aug; 63(8):751-7. PubMed ID: 22660524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for a multi-centre, definitive randomised controlled trial of the effectiveness of Individual Placement and Support for employment support among people with alcohol and drug dependence.
    Marsden J; Anders P; Clark H; Colocassis K; Eastwood B; Knight J; Melaugh A; Quinn D; Wright V; Stannard J
    Trials; 2020 Feb; 21(1):167. PubMed ID: 32046765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.